Critical Therapeutics to Report Second-Quarter 2007 Financial Results on August 8.LEXINGTON, Mass. -- Critical Therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. , Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CRTX) will conduct a conference call at 5:00 p.m. (ET) on Wednesday, August 8, following the release of its second-quarter 2007 financial results. Critical Therapeutics' President and Chief Executive Officer, Frank Thomas Frank Thomas may refer to:
Investors and others are invited to listen live via telephone or the Internet Internet Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the .
What: Critical Therapeutics Second-Quarter 2007 Financial
Results Conference Call
When: 5:00 p.m. (ET) Wednesday, August 8, 2007
Dial-in: From the U.S. and Canada, dial (800) 310-1961
International callers, dial (719) 457-2692
Webcast: Visit www.crtx.com, select "Investors" and then click
on the conference call link.
Replay: Visit www.crtx.com, select "Investors" and then
"Webcasts & Presentations."
About Critical Therapeutics Critical Therapeutics, Inc. is developing and commercializing innovative products for respiratory, inflammatory and critical care diseases. The Company owns worldwide rights to two FDA-approved drugs for the prevention and chronic treatment of asthma in patients 12 years of age and older: twice-daily ZYFLO CR[TM] (zileuton zileuton /zi·leu·ton/ (zi-loo´ton) an inhibitor of leukotriene formation, used as an antiasthmatic. Zileuton (Zyflo) ) extended-release tablets and ZYFLO[R] (zileuton tablets). Critical Therapeutics is working to develop products for acute asthma attacks that lead patients to the emergency room and other urgent care settings. The Company also is developing therapies directed toward the body's inflammatory response. Critical Therapeutics is located in Lexington, Massachusetts Lexington is a town in Middlesex County, Massachusetts, United States. The population was 30,355 at the 2000 census. The town is famous for being the site of the opening shots of the Battles of Lexington and Concord, the first engagement of the American Revolution. . For more information, please visit www.crtx.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion